Literature DB >> 15533615

How PEDF prevents angiogenesis: a hypothesized pathway.

Jian-Guo Ren1, Chunfa Jie, Conover Talbot.   

Abstract

Pigment epithelium-derived factor (PEDF) is a multiple functional protein, coded by the serine proteinase inhibitor, clade F, member 1 (SERPINF1) gene, which has both anti-angiogenic activity and neurotrophic activity at the same time. Its antiangiogenic activity in the mammalian eye is the most potent known at this time. However, the mechanism(s) by which PEDF works in vivo is still uncertain. Some observations suggest that PEDF can simultaneously inhibit the migration and proliferation induced by vascular endothelial growth factor (VEGF), and then further inhibits angiogenesis by interacting with specific cell surface receptors, but no such receptor has been reported to date. Here we propose a hypothesis that PEDF exerts its function by binding with intergrins. Intergrin can therefore serve as the receptor of PEDF.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15533615     DOI: 10.1016/j.mehy.2004.05.016

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  11 in total

1.  Loss of keratinocytic RXRα combined with activated CDK4 or oncogenic NRAS generates UVB-induced melanomas via loss of p53 and PTEN in the tumor microenvironment.

Authors:  Daniel J Coleman; Sharmeen Chagani; Stephen Hyter; Anna M Sherman; Christiane V Löhr; Xiaobo Liang; Gitali Ganguli-Indra; Arup K Indra
Journal:  Mol Cancer Res       Date:  2014-09-04       Impact factor: 5.852

2.  Pigment epithelium-derived factor expression is down-regulated in bladder tumors and correlates with vascular endothelial growth factor and matrix metalloproteinase-9.

Authors:  Chen-Chen Feng; Qiang Ding; Yuan-Fang Zhang; Hao-Wen Jiang; Hui Wen; Pao-Hsun Wang; Zhong Wu
Journal:  Int Urol Nephrol       Date:  2010-09-17       Impact factor: 2.370

Review 3.  Therapeutic implications of curcumin in the prevention of diabetic retinopathy via modulation of anti-oxidant activity and genetic pathways.

Authors:  Yousef H Aldebasi; Salah M Aly; Arshad H Rahmani
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2013-12-15

4.  A Chronic Fatigue Syndrome - related proteome in human cerebrospinal fluid.

Authors:  James N Baraniuk; Begona Casado; Hilda Maibach; Daniel J Clauw; Lewis K Pannell; Sonja Hess S
Journal:  BMC Neurol       Date:  2005-12-01       Impact factor: 2.474

5.  Tumour angiogenesis in Epstein-Barr virus-associated post-transplant smooth muscle tumours.

Authors:  Danny Jonigk; Nicole Izykowski; Lavinia Maegel; Eileen Schormann; Britta Ludewig; Hans Kreipe; Kais Hussein
Journal:  Clin Sarcoma Res       Date:  2014-01-07

6.  Transformation of the Transcriptomic Profile of Mouse Periocular Mesenchyme During Formation of the Embryonic Cornea.

Authors:  Justin Ma; Peter Lwigale
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-02-01       Impact factor: 4.799

7.  Weight changes in hypertensive patients with phlegm-dampness syndrome: an integrated proteomics and metabolomics approach.

Authors:  Chi Zhang; Li Li; Shiping Cheng; Debajyoti Chowdhury; Yong Tan; Xinru Liu; Ning Zhao; Xiaojuan He; Miao Jiang; Cheng Lu; Aiping Lyu
Journal:  Chin Med       Date:  2021-07-07       Impact factor: 5.455

8.  Inhibition of corneal neovascularization with the combination of bevacizumab and plasmid pigment epithelium-derived factor-synthetic amphiphile INTeraction-18 (p-PEDF-SAINT-18) vector in a rat corneal experimental angiogenesis model.

Authors:  Chien-Neng Kuo; Chung-Yi Chen; San-Ni Chen; Lin-Cheng Yang; Li-Ju Lai; Chien-Hsiung Lai; Miao-Fen Chen; Chia-Hui Hung; Ching-Hsein Chen
Journal:  Int J Mol Sci       Date:  2013-04-16       Impact factor: 5.923

9.  Mesenchymal stem cells overexpressing PEDF decrease the angiogenesis of gliomas.

Authors:  Qiaoshu Wang; Zhaoyun Zhang; Tianling Ding; Zi Chen; Tao Zhang
Journal:  Biosci Rep       Date:  2013-02-01       Impact factor: 3.840

Review 10.  Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas.

Authors:  Qing Zhang; Wei Xiang; Dong-Ye Yi; Bing-Zhou Xue; Wan-Wan Wen; Ahmed Abdelmaksoud; Nan-Xiang Xiong; Xiao-Bing Jiang; Hong-Yang Zhao; Peng Fu
Journal:  Stem Cell Res Ther       Date:  2018-08-24       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.